preloader

Email Us

info@prorelixresearch.com

Single Blog

CRO market in Asia to show ‘significant growth’ by 2020

According to the report, published by Frost & Sullivan, the global contract research organization (CRO) market is expected to grow at a compound annual growth rate (CAGR) of 12.4% to reach $57bn in 2020, up from $31.8bn in 2015.

Increased R&D activity and shift toward outsourcing are key drivers of this growth, according to the report with the potential to outsource more than three-quarters of R&D spending by biotechnology and pharmaceutical companies.

As such, the report explained a“significant increase in the CRO market” is expected, growth that will be catalyzed by increased outsourcing, as penetration is expected to increase from 28.9% in 2015 to nearly 43% in 2020.

Source –

1) https://www.outsourcing-pharma.com/Article/2017/03/06/CRO-market-in-Asia-to-see-significant-increase through-2020

2) Frost & Sullivan Report

Niranjan Andhalkar

https://prorelixresearch.com/mr-niranjan-andhalkar/

( Director – Strategic Management & Planning ) - Mr. Niranjan Andhalkar is a visionary leader with more than 17 years of proven expertise in clinical research, strategic management, and business innovation. Recognized for his ability to blend entrepreneurial spirit with strategic foresight, he has successfully built, scaled, and transformed businesses across Contract Research Organizations (CROs), pharmaceuticals, healthcare IT. His dynamic leadership style and relentless pursuit of excellence have positioned him as a trusted figure in the international clinical research ecosystem. A seasoned strategist, Mr. Andhalkar is celebrated for his work to drive growth, enhance operational efficiency, and create sustainable value in highly competitive markets. He has an exceptional track record of fostering strategic alliances, steering multinational collaborations, and spearheading business innovations that have consistently set new benchmarks in the industry. His influence extends beyond corporate leadership, as he also contributes to the advancement of science and innovation through advisory and editorial roles in reputed international journals. Passionate about shaping the future of healthcare, Mr. Andhalkar is deeply committed to creating organizations that not only achieve financial success but also set new standards of quality, integrity, and impact in the industry. His leadership continues to inspire teams, empower clients, and redefine benchmarks across the global clinical research ecosystem. Mr. Andhalkar holds advanced academic credentials in both Life Sciences and Management. He earned his graduation in Biotechnology, followed by a postgraduate degree in Clinical Research, equipping him with deep scientific expertise. To complement his technical foundation, he pursued an MBA in Operations Management, which has enabled him to successfully integrate scientific rigor with business strategy—driving innovation, operational excellence, and long-term sustainability across his ventures.

Subscribe to our Newsletter

Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.

[fluentform id="3"]
prorelix research

ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.